NEWSROOM

September 5, 2024

SHL announces Special General Meeting Results

September 3, 2024

Ad-hoc announcement pursuant to Art. 53 LR

SHL Telemedicine to appoint Dr. Itamar Offer as Chairman of the Company’s Board of Directors

August 26, 2024

Ad-hoc announcement pursuant to Art. 53 LR

SHL Telemedicine’s Chairman announced he is stepping down

August 2, 2024

Ad-hoc announcement pursuant to Art. 53 LR

SHL Telemedicine’s Chairman intends to step down in the near term

July 31, 2024

SHL announces invitation to a Special General Meeting

July 29, 2024

Ad-hoc announcement pursuant to Art. 53 LR

SHL Telemedicine to appoint David Arnon as CEO of SHL Telemedicine

June 25, 2024

SHL Telemedicine provides an update regarding CEO position

June 20, 2024

Ad-hoc announcement pursuant to Art. 53 LR

SHL Telemedicine confirms discussions regarding a possible investment in its Israeli activity

May 21, 2024

SHL Telemedicine expands offering in Israel with groundbreakingat-home Biomarker blood test